Soluble programmed death-1 is a useful indicator for mortality in patients with adult-onset Still's disease

Int J Rheum Dis. 2024 Jun;27(6):e15240. doi: 10.1111/1756-185X.15240.

Authors

Se Rim Choi¹, Ju Ho Lee¹, Eun Ha Kang^{1

2}, Yun Jong Lee^{1

2}, Jung Yoon Pyo³, Yong-Beom Park³, Mi-Hyun Ahn⁴, Hyoun-Ah Kim⁴, You-Jung Ha^{1

2}

Affiliations

¹ Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea.
² Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
³ Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
⁴ Department of Rheumatology, Ajou University School of Medicine, Suwon, Gyeonggi-do, Korea.

PMID: 38923317
DOI: 10.1111/1756-185X.15240

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Biomarkers* / blood
Female
Humans
Male
Middle Aged
Predictive Value of Tests
Prognosis
Programmed Cell Death 1 Receptor* / blood
Risk Factors
Still's Disease, Adult-Onset* / blood
Still's Disease, Adult-Onset* / diagnosis
Still's Disease, Adult-Onset* / drug therapy
Still's Disease, Adult-Onset* / mortality
Time Factors

Substances

Biomarkers
Programmed Cell Death 1 Receptor
PDCD1 protein, human